Journal of pharmacy & bioallied sciences · 2026
Efficacy of Azithromycin 1% in the Clinical Management of Bacterial Conjunctivitis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Suthar Apurva H
Аннотация
AIM: To evaluate the clinical efficacy and safety of topical azithromycin 1% ophthalmic preparation in bacterial conjunctivitis.
MATERIALS AND METHODS: A prospective observational study was conducted on 150 patients clinically diagnosed with bacterial conjunctivitis and treated with topical azithromycin 1%. Clinical response and adverse events were assessed during follow-up.
RESULTS: High clinical cure rates were observed with minimal adverse effects, indicating good efficacy and tolerability.
CONCLUSION: Topical azithromycin 1% is a safe and effective treatment option for bacterial conjunctivitis in routine clinical practice.
MATERIALS AND METHODS: A prospective observational study was conducted on 150 patients clinically diagnosed with bacterial conjunctivitis and treated with topical azithromycin 1%. Clinical response and adverse events were assessed during follow-up.
RESULTS: High clinical cure rates were observed with minimal adverse effects, indicating good efficacy and tolerability.
CONCLUSION: Topical azithromycin 1% is a safe and effective treatment option for bacterial conjunctivitis in routine clinical practice.